home / stock / oxfd / oxfd news

OXFD News and Press, Oxford Immunotec Global PLC From 09/29/20

Stock Information
Company Name: Oxford Immunotec Global PLC
Stock Symbol: OXFD
Market: NASDAQ
Website: oxfordimmunotec.com
Menu
OXFD OXFD Quote OXFD Short OXFD News OXFD Articles OXFD Message Board
Get OXFD Alerts

News, Short Squeeze, Breakout and More Instantly...
OXFD - Oxford Immunotec Announces Food and Drug Administration (FDA) Clearance of the T-SPOT®.TB Test for Use in Pediatrics Over the Age of Two

OXFORD, United Kingdom and MARLBOROUGH, Mass., Sept. 29, 2020 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD) (the “Company”), a global, high-growth diagnostics company, today announced that it has received clearance from the FDA to amend the pediatric age limita...
OXFD - Oxford Immunotec Joins Forces with Public Health England (PHE) in a Large Clinical Trial Utilizing T-SPOT® Discovery(TM) SARS-CoV-2 Test

OXFORD, United Kingdom and MARLBOROUGH, Mass., Sept. 22, 2020 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq: OXFD) (the “Company”), a global, high-growth diagnostics company, today announced that it has entered into an extensive research collaboration with Public Hea...

OXFD - Oxford Immunotec Global PLC (OXFD) CEO Peter Wrighton-Smith on Q2 2020 Results - Earnings Call Transcript

Oxford Immunotec Global PLC (OXFD) Q1 2021 Earnings Conference Call August 04, 2020 08:00 AM ET Company Participants Matt McLaughlin - Chief Financial Officer Peter Wrighton-Smith - Chief Executive Officer Conference Call Participants Sung Ji Nam - BTIG Chris Lin - Cowen ...

OXFD - Oxford Immunotec Global PLC (OXFD) Q2 2020 Earnings Call Transcript

Image source: The Motley Fool. Oxford Immunotec Global PLC   (NASDAQ: OXFD) Q2 2020 Earnings Call Aug 4, 2020 , 8:00 a.m. ET Operator Continue reading

OXFD - Oxford Immunotec Global PLC 2020 Q2 - Results - Earnings Call Presentation

The following slide deck was published by Oxford Immunotec Global PLC in conjunction with their 2020 Q2 earnings Read more ...

OXFD - Oxford Immunotec Global EPS misses by $0.07, revenue in-line

Oxford Immunotec Global (NASDAQ: OXFD ) : Q2 GAAP EPS of -$0.37 misses by $0.07 . More news on: Oxford Immunotec Global PLC, Earnings news and commentary, Healthcare stocks news, Read more ...

OXFD - Oxford Immunotec Reports Second Quarter 2020 Financial Results

Second quarter revenue of $5.8 million, a decrease of 70% compared to prior year period, due to the impact of COVID-19 Ended the quarter with approximately $165 million of cash and cash equivalents Third quarter revenue estimated to be between $18 - $19 million OXFORD, United ...
OXFD - Oxford Immunotec Schedules Second Quarter 2020 Earnings Release and Conference Call for August 4, 2020

OXFORD, United Kingdom and MARLBOROUGH, Mass., July 21, 2020 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD) (the "Company"), a global, high-growth diagnostics company, today announced that it plans to release second quarter 2020 financial results before the open of the market...

OXFD - Oxford Immunotec Announces Agreement with Stop TB Partnership - Global Drug Facility (GDF) to Provide Access to the T-SPOT®.TB Test for 100+ TB Burden Countries

OXFORD, United Kingdom and MARLBOROUGH, Mass., July 20, 2020 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD) (the "Company"), today announced that it has entered into a long-term agreement to supply its T-SPOT. TB test and associated accessories to the Stop TB Partnership - Glob...

OXFD - Oxford Immunotec releases the T-SPOT® Discovery(TM) SARS-CoV-2 kit for research into measuring the T cell immune response to SARS-CoV-2, which may offer new insights into immunity to COVID-19

OXFORD, United Kingdom and MARLBOROUGH, Mass., May 19, 2020 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq: OXFD) (the “Company”), a global, high-growth diagnostics company, today announces the release of the T-SPOT Discovery SARS-CoV-2 test kit. This kit is for resear...
Previous 10 Next 10